Higher antiviral activity of antiretroviral regimens including protease inhibitors

被引：8

作者：

de Mendoza, C ^{[1
]}

Soriano, V ^{[1
]}

Rodríguez-Rosado, R ^{[1
]}

González-Lahoz, J ^{[1
]}

机构：

[1] Hosp Carlos III, Inst Salud Carlos III, Infect Dis Serv, Madrid, Spain

来源：

AIDS | 1999年 / 13卷 / 08期

关键词：

D O I：

10.1097/00002030-199905280-00021

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：998 / 999

页数：2

共 9 条

[1] Resisting resistance: Maximizing the durability of antiretroviral therapy
Condra, JH
[J]. ANNALS OF INTERNAL MEDICINE, 1998, 128 (11) : 951 - 954
[2] HIV treatment strategies - Planning for the long term
Gulick, RM
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (12): : 957 - 959
[3] Günthard HF, 1998, J VIROL, V72, P2422
[4] Antiretroviral drug resistance testing in adults with HIV infection -: Implications for clinical management
Hirsch, MS
Conway, B
D'Aquila, RT
Johnson, VA
Brun-Vézinet, F
Clotet, B
Demeter, LM
Hammer, SM
Jacobsen, DM
Kuritzkes, DR
Loveday, C
Mellors, JW
Vella, S
Richman, DD
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (24): : 1984 - 1991
[5] An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma
Kern, D
Collins, M
Fultz, T
Detmer, J
Hamren, S
Peterkin, JJ
Sheridan, P
Urdea, M
White, R
Yeghiazarian, T
Todd, J
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (12) : 3196 - 3202
[6] HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
Perelson, AS
Neumann, AU
Markowitz, M
Leonard, JM
Ho, DD
[J]. SCIENCE, 1996, 271 (5255) : 1582 - 1586
[7] Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue
Ruiz, L
van Lunzen, J
Arno, A
Stellbrink, HJ
Schneider, C
Rull, M
Castellà, E
Ojanguren, I
Richman, DD
Clotet, B
Tenner-Racz, K
[J]. AIDS, 1999, 13 (01) : F1 - F8
[8] Protease inhibitors as initial therapy for individuals with an intermediate risk of HIV disease progression: is more necessarily better?
Schechter, M
Struchiner, CJ
Harrison, LH
[J]. AIDS, 1999, 13 (01) : 97 - 102
[9] QUANTIFICATION OF HIV-1 RNA IN PLASMA USING NASBA (TM) DURING HIV-1 PRIMARY INFECTION
VANGEMEN, B
KIEVITS, T
SCHUKKINK, R
VANSTRIJP, D
MALEK, LT
SOOKNANAN, R
HUISMAN, HG
LENS, P
[J]. JOURNAL OF VIROLOGICAL METHODS, 1993, 43 (02) : 177 - 188

← 1 →